Abstract
There is increasing acknowledgment of the public health burden of metabolic syndrome. The metabolic syndrome is defined as emerging cardiovascular risk factors, or atherosclerosis, that are related to underlying insulin resistance. One of the adipokines, adiponectin, has antiatherogenic effects and augments the metabolic effects of insulin. To reduce mortality from cardiovascular disease, it is important to understand the pathophysiological properties of adiponectin and receptors in atherosclerotic regions. Recently, T-cadherin, which has been recognized as a unique cadherin molecule, has been characterized as a novel adiponectin receptor on vascular endothelial cells and smooth muscle. Notably, T-cadherin (also known as CDH13, cadherin 13, and H-cadherin) is abundantly expressed in injured vascular endothelial and smooth muscle cells in atherosclerotic regions. In the present review, we describe recent progress in research on adiponectin receptors, with emphasis on the unique vascular adiponectin receptor, T-cadherin, and its role in vascular disease.
Similar content being viewed by others
References
M Nishida T Funahashi I Shimomura (2007) ArticleTitlePathophysiological significance of adiponectin Med Mol Morphol 40 55–67 Occurrence Handle17572841 Occurrence Handle10.1007/s00795-007-0366-7 Occurrence Handle1:CAS:528:DC%2BD2sXmsFKiur8%3D
K Takashi T Yamauchi N Kubota K Hara K Ueki K Tobe (2006) ArticleTitleAdiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome J Clin Invest 116 1784–1792 Occurrence Handle10.1172/JCI29126
WS Yang WJ Lee T Funahashi S Tanaka Y Matsuzawa CL Chao CL Chen TY Tai LM Chuang (2002) ArticleTitleWeight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin J Clin Endocrinol Metab 86 3815–3819 Occurrence Handle10.1210/jc.86.8.3815
K Hotta T Funahashi Y Arita M Takahashi M Matsuda Y Okamoto H Iwahashi H Kuriyama N Ouchi K Maeda M Nishida S Kihara N Sakai T Nakajima K Hasegawa M Muraguchi Y Ohmoto T Nakamura S Yamashita T Hanafusa Y Matsuzawa (2000) ArticleTitlePlasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients Arterioscler Thromb Vasc Biol 20 1595–1599 Occurrence Handle10845877 Occurrence Handle1:CAS:528:DC%2BD3cXksVCgt7c%3D
C Zoccali F Mallamaci G Tripepi FA Benedetto S Cutrupi S Parlongo LS Malatino G Bonanno G Seminara F Rapisarda P Fatuzzo M Buemi G Nicocia S Tanaka N Ouchi S Kihara T Funahashi Y Matsuzawa (2002) ArticleTitleAdiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease J Am Soc Nephrol 13 134–141 Occurrence Handle11752030 Occurrence Handle10.1097/01.ASN.0000032548.18973.0F Occurrence Handle1:CAS:528:DC%2BD38XltV2gsQ%3D%3D
N Ouchi S Kihara Y Arita M Nishida A Matsuyama Y Okamoto M Ishigami H Kuriyama K Kishida H Nishizawa K Hotta M Muraguchi Y Ohmoto S Yamashita T Funahashi Y Matsuzawa (2001) ArticleTitleAdipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages Circulation 103 1057–1063 Occurrence Handle11222466 Occurrence Handle1:CAS:528:DC%2BD3MXisFent74%3D
Y Okamoto S Kihara N Ouchi M Nishida Y Arita M Kumada K Ohashi N Sakai I Shimomura H Kobayashi N Terasaka T Inaba T Funahashi Y Matsuzawa (2002) ArticleTitleAdiponectin reduces atherosclerosis in apolipoprotein E-deficient mice Circulation 106 2767–2770 Occurrence Handle12451000 Occurrence Handle10.1161/01.CIR.0000042707.50032.19 Occurrence Handle1:CAS:528:DC%2BD38XoslSnsbw%3D
AS Plump JD Smith T Hayek K Aalto-Setala A Walsh JG Verstuyft EM Rubin JL Breslow (1992) ArticleTitleSevere hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells Cell 71 343–353 Occurrence Handle1423598 Occurrence Handle10.1016/0092-8674(92)90362-G Occurrence Handle1:CAS:528:DyaK38XmsV2ns74%3D
T Yamauchi J Kamon Y Ito A Tsuchida T Yokomizo S Kita T Sugiyama M Miyagishi K Hara M Tsunoda K Murakami T Ohteki S Uchida S Takekawa H Waki NH Tsuno Y Shibata Y Terauchi P Froguel K Tobe S Koyasu K Taira T Kitamura T Shimizu R Nagai T Kadowaki (2003) ArticleTitleCloning of adiponectin receptors that mediate antidiabetic metabolic effects Nature (Lond) 423 762–769 Occurrence Handle10.1038/nature01705 Occurrence Handle1:CAS:528:DC%2BD3sXksV2itL8%3D
H Motoshima X Wu K Mahadev BJ Goldstein (2004) ArticleTitleAdiponectin suppresses proliferation and superoxide generation and enhances eNOS activity in endothelial cells treated with oxidized LDL Biochem Biophys Res Commun 315 264–271 Occurrence Handle14766203 Occurrence Handle10.1016/j.bbrc.2004.01.049 Occurrence Handle1:CAS:528:DC%2BD2cXps1OhsA%3D%3D
N Ouchi S Kihara Y Arita M Nishida A Matsuyama Y Okamoto M Ishigami H Kuriyama K Kishida H Nishizawa K Hotta M Muraguchi Y Ohmoto S Yamashita T Funahashi Y Matsuzawa (2001) ArticleTitleAdipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages Circulation 103 1057–1063 Occurrence Handle11222466 Occurrence Handle1:CAS:528:DC%2BD3MXisFent74%3D
C Hug J Wang NS Ahmad JS Bogan TS Tsao HF Lodish (2004) ArticleTitleT-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin Proc Natl Acad Sci U S A 101 10308–10313 Occurrence Handle15210937 Occurrence Handle10.1073/pnas.0403382101 Occurrence Handle1:CAS:528:DC%2BD2cXmtVyku7c%3D
B Ranscht MT Dours-Zimmermann (1991) ArticleTitleT-cadherin, a novel cadherin cell adhesion molecule in the nervous system, lacks the conserved cytoplasmic region Neuron 7 391–402 Occurrence Handle1654948 Occurrence Handle10.1016/0896-6273(91)90291-7 Occurrence Handle1:CAS:528:DyaK3sXktlek
SW Lee (1996) ArticleTitleH-cadherin, a novel cadherin with growth inhibitory functions and diminished expression in human breast cancer Nat Med 2 776–782 Occurrence Handle8673923 Occurrence Handle10.1038/nm0796-776 Occurrence Handle1:CAS:528:DyaK28XjvF2isrw%3D
H Tanihara K Sano RL Heimark T St. John S Suzuki (1994) ArticleTitleCloning of five human cadherins clarifies characteristic features of cadherin extracellular domain and provides further evidence for two structurally different types of cadherin Cell Adhesion Commun 2 15–26 Occurrence Handle1:CAS:528:DyaK2MXhs1ehtg%3D%3D
A Nagafuchi M Takeichi (1988) ArticleTitleCell binding function of E-cadherin is regulated by the cytoplasmic domain EMBO J 7 3679–3684 Occurrence Handle3061804 Occurrence Handle1:CAS:528:DyaL1MXjsFKgtg%3D%3D
S Zhou N Matsuyoshi SB Liang T Takeuchi Y Ohtsuki Y Miyachi (2002) ArticleTitleExpression of T-cadherin in basal keratinocytes of skin J Invest Dermatol 118 1080–1084 Occurrence Handle12060406 Occurrence Handle10.1046/j.1523-1747.2002.01795.x Occurrence Handle1:CAS:528:DC%2BD38XlsV2rtr4%3D
T Takeuchi SB Liang N Matsuyoshi S Zhou Y Miyachi H Sonobe Y Ohtsuki (2002) ArticleTitleLoss of T-cadherin (CDH13, H-cadherin) expression in cutaneous squamous cell carcinoma Lab Invest 82 1023–1029 Occurrence Handle12177241 Occurrence Handle1:CAS:528:DC%2BD38XntVeqsLw%3D
T Takeuchi Y Ohtsuki (2001) ArticleTitleRecent progress of T-cadherin (CDH13, H-cadherin) research Histol Histopathol 16 1287–1293 Occurrence Handle11642747 Occurrence Handle1:CAS:528:DC%2BD3MXpt1Srtb8%3D
M Sato Y Mori A Sakurada S Fujimura A Horii (1998) ArticleTitleThe H-cadherin (CDH13) gene is inactivated in human lung cancer Hum Genet 103 96–101 Occurrence Handle9737784 Occurrence Handle10.1007/s004390050790 Occurrence Handle1:CAS:528:DyaK1cXks12htrc%3D
KO Toyooka S Toyooka AK Virmani UG Sathyanarayana DM Euhus M Gilcrease JD Minna AF Gazdar (2001) ArticleTitleLoss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomas Cancer Res 61 4556–4560 Occurrence Handle11389090 Occurrence Handle1:CAS:528:DC%2BD3MXktlWjsL0%3D
T Takeuchi SB Liang Y Ohtsuki (2002) ArticleTitleDownregulation of expression of a novel cadherin molecule, T-cadherin, in basal cell carcinoma of the skin Mol Carcinog 35 173–179 Occurrence Handle12489108 Occurrence Handle10.1002/mc.10088 Occurrence Handle1:CAS:528:DC%2BD3sXis1ykug%3D%3D
S Toyooka KO Toyooka K Harada K Miyajima P Makarla UG Sathyanarayana J Yin F Sato N Shivapurkar SJ Meltzer AF Gazdar (2002) ArticleTitleAberrant methylation of the CDH13 (H-cadherin) promoter region in colorectal cancers and adenomas Cancer Res 62 3382–3386 Occurrence Handle12067979 Occurrence Handle1:CAS:528:DC%2BD38XkslWqsLY%3D
J Roman-Gomez JA Castillejo A Jimenez F Cervantes C Boque L Hermosin A Leon A Granena D Colomer A Heiniger A Torres (2003) ArticleTitleCadherin-13, a mediator of calcium-dependent cell-cell adhesion, is silenced by methylation in chronic myeloid leukemia and correlates with pretreatment risk profile and cytogenetic response to interferon alfa J Clin Oncol 21 1472–1429 Occurrence Handle12697869 Occurrence Handle10.1200/JCO.2003.08.166 Occurrence Handle1:CAS:528:DC%2BD2cXptlCks7c%3D
M Sakai K Hibi K Koshikawa S Inoue S Takeda T Kaneko A Nakao (2004) ArticleTitleFrequent promoter methylation and gene silencing of CDH13 in pancreatic cancer Cancer Sci 95 588–591 Occurrence Handle15245595 Occurrence Handle10.1111/j.1349-7006.2004.tb02491.x Occurrence Handle1:CAS:528:DC%2BD2cXnt1Wjsbk%3D
T Fukuoka K Hibi A Nakao (2006) ArticleTitleAberrant methylation is frequently observed in advanced esophageal squamous cell carcinoma Anticancer Res 26 3333–3335 Occurrence Handle17094449 Occurrence Handle1:CAS:528:DC%2BD28Xht1ersL7O
Y Ogama M Ouchida T Yoshino S Ito H Takimoto Y Shiote F Ishimaru M Harada M Tanimoto K Shimizu (2004) ArticleTitlePrevalent hyper-methylation of the CDH13 gene promoter in malignant B cell lymphomas Int J Oncol 25 685–691 Occurrence Handle15289870 Occurrence Handle1:CAS:528:DC%2BD2cXnt1Ogsr0%3D
D Sun Z Zhang DN Van G Huang I Ernberg L Hu (2006) ArticleTitleAberrant methylation of CDH13 gene in nasopharyngeal carcinoma could serve as a potential diagnostic biomarker Oral Oncol 43 82–87 Occurrence Handle16807071 Occurrence Handle10.1016/j.oraloncology.2006.01.007
L Wyder A Vitaliti H Schneider LW Hebbard DR Moritz M Wittmer M Ajmo R Klemenz (2000) ArticleTitleIncreased expression of H/T-cadherin in tumor-penetrating blood vessels Cancer Res 60 4682–4688 Occurrence Handle10987267 Occurrence Handle1:CAS:528:DC%2BD3cXmsFWiu78%3D
Y Adachi T Takeuchi H Sonobe Y Ohtsuki (2006) ArticleTitleAn adiponectin receptor, T-cadherin, was selectively expressed in intratumoral capillary endothelial cells in hepatocellular carcinoma: possible cross talk between T-cadherin and FGF-2 pathways Virchows Arch 448 311–318 Occurrence Handle16273386 Occurrence Handle10.1007/s00428-005-0098-9 Occurrence Handle1:CAS:528:DC%2BD28XitFOhsLs%3D
MB Joshi M Philippova D Ivanov R Allenspach P Erne TJ Resink (2005) ArticleTitleT-cadherin protects endothelial cells from oxidative stress-induced apoptosis FASEB J 19 1737–1739 Occurrence Handle16099944 Occurrence Handle1:CAS:528:DC%2BD2MXhtFSjsbfM
R Stocker JF Keaney SuffixJr (2004) ArticleTitleRole of oxidative modifications in atherosclerosis Physiol Rev 84 1381–1478 Occurrence Handle15383655 Occurrence Handle10.1152/physrev.00047.2003 Occurrence Handle1:CAS:528:DC%2BD2cXovVyltbo%3D
R Ouedraogo X Wu SQ Xu L Fuchsel H Motoshima K Mahadev K Hough R Scalia BJ Goldstein (2006) ArticleTitleAdiponectin suppression of high-glucose-induced reactive oxygen species in vascular endothelial cells: evidence for involvement of a cAMP signaling pathway Diabetes 55 1840–1846 Occurrence Handle16731851 Occurrence Handle10.2337/db05-1174 Occurrence Handle1:CAS:528:DC%2BD28XlsF2qsr8%3D
M Qin Z Zeng J Zheng PK Shah SM Schwartz LD Adams BG Sharifi (2003) ArticleTitleSuppression subtractive hybridization identifies distinctive expression markers for coronary and internal mammary arteries Arterioscler Thromb Vasc Biol 23 425–433 Occurrence Handle12615697 Occurrence Handle10.1161/01.ATV.0000059303.94760.5C Occurrence Handle1:CAS:528:DC%2BD3sXhslWhsLc%3D
S Bai K Ghoshal ST Jacob (2006) ArticleTitleIdentification of T-cadherin as a novel target of DNA methyltransferase 3B and its role in the suppression of nerve growth factor-mediated neurite outgrowth in PC12 cells J Biol Chem 281 13604–13611 Occurrence Handle16537533 Occurrence Handle10.1074/jbc.M513278200 Occurrence Handle1:CAS:528:DC%2BD28Xkt1ymtLs%3D
C Bromhead JH Miller FJ McDonald (2006) ArticleTitleRegulation of T-cadherin by hormones, glucocorticoid and EGF Gene (Amst) 374 58–67 Occurrence Handle1:CAS:528:DC%2BD28XkvVWrsr0%3D
T Takeuchi A Misaki S-B Liang A Tachibana N Hayashi H Sonobe Y Ohtsuki (2000) ArticleTitleExpression of T-cadherin (CDH13, H-cadherin) in human brain and its characteristics as a negative growth regulator of EGF in neuroblastoma cells J Neurochem 74 1489–1497 Occurrence Handle10737605 Occurrence Handle10.1046/j.1471-4159.2000.0741489.x Occurrence Handle1:CAS:528:DC%2BD3cXitVegt7o%3D
ZY Huang Y Wu N Hedrick DH Gutmann (2003) ArticleTitleT-cadherin-mediated cell growth regulation involves G2 phase arrest and requires p21 (CIP1/WAF1) expression Mol Cell Biol 23 566–578 Occurrence Handle12509455 Occurrence Handle10.1128/MCB.23.2.566-578.2003 Occurrence Handle1:CAS:528:DC%2BD3sXjslWqtg%3D%3D
D Ivanov M Philippova J Antropova F Gubaeva O Iljinskaya E Tararak V Bochkov P Erne T Resink V Tkachuk (2001) ArticleTitleExpression of cell adhesion molecule T-cadherin in the human vasculature Histochem Cell Biol 115 231–242 Occurrence Handle11326751 Occurrence Handle1:CAS:528:DC%2BD3MXjtFWqurs%3D
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Takeuchi, T., Adachi, Y., Ohtsuki, Y. et al. Adiponectin receptors, with special focus on the role of the third receptor, T-cadherin, in vascular disease. Med Mol Morphol 40, 115–120 (2007). https://doi.org/10.1007/s00795-007-0364-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00795-007-0364-9